BlackRock, Inc.

Position in INCY — Incyte Corp

CIK 2012383 New York, NY

Position in INCY

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$2,044,188,902

+$257,960,917 QoQ

Shares Held

18,032,718

-5.0% QoQ

Ownership

9.03%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

of 849 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 92% Shared 0% None 8%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $85,016,936,299 across 474 Biotechnology names. INCY ranks #6 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	24,109,373	$11,975,848,839
2	REGN	Regeneron Pharmaceuticals, Inc.	9,113,506	$5,682,635,520
3	ALNY	Alnylam Pharmaceuticals, Inc.	10,907,675	$3,283,537,392
4	RVMD	Revolution Medicines, Inc.	13,695,790	$2,564,947,540
5	MRNA	Moderna, Inc.	30,599,409	$2,142,876,602
6	INCY	Incyte Corp This page	18,032,718	$2,044,188,902
7	CYTK	Cytokinetics Inc	20,094,362	$1,711,838,691
8	ROIV	Roivant Sciences Ltd.	48,236,091	$1,707,075,250

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,044,188,902	18,032,718	-5.0%	Shares	Sole	2026-08-07
2026-03-31	$1,786,227,985	18,978,198	+3.5%	Shares	Sole	2026-05-13
2025-12-31	$1,810,248,944	18,327,923	+2.4%	Shares	Sole	2026-02-12
2025-09-30	$1,517,615,321	17,894,297	-0.3%	Shares	Sole	2025-11-12
2025-06-30	$1,222,858,612	17,956,808	+3.0%	Shares	Sole	2025-08-12
2025-03-31	$1,055,573,649	17,433,091	+5.6%	Shares	Sole	2025-05-02
2024-12-31	$1,140,377,947	16,510,467	-3.3%	Shares	Sole	2025-02-07
2024-09-30	$1,128,839,925	17,077,760	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.